Adam R. Craig, EVP, Development & CMO at SUNESIS PHARMACEUTICALS INC (SNSS), sold 2,554 shares at $8.00 ($20K) on 2014-08-27, disclosed to the SEC on 2014-08-29.
Scheduled sale ($20k) by EVP, Development & CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CTIC | SELL | 2023-01-26 | $512K | — | Filing → |
| CTIC | SELL | 2023-01-03 | $1.2M | — | Filing → |
| CTIC | SELL | 2022-11-14 | $1.6M | — | Filing → |